The results are a welcome bit of news amid the explosive rise of Omicron cases and evidence that the strain can evade the protection that normally stems from vaccination.
The J&J vaccine appears to provide some defense against Omicron, perhaps via other means such as stimulation of immune cells, according to a South African virologist.
Researchers noted that the risk of blood clots should be considered in context of the vaccine’s efficacy, saying it is effective in offering protection from severe Covid-19.
The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.
The Centers for Disease Control & Prevention will consult an expert panel later this week before finalising official recommendations for who should get boosters and when.
US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.
With the approval of the single-dose J&J vaccine, India has five vaccines that have got approval for emergency use. The others are Covishield, Covaxin, Sputnik V and Moderna.
Johnson & Johnson Friday said that it remains committed to bringing the single-dose vaccine and accelerating its availability in India through collaboration with Biological E.
The cut in excise duty last week, coupled with an increase in fertiliser and food subsidies, is expected to cost the exchequer around Rs 3 lakh crore in the current financial year.
India is 35th member of the maritime counterterrorism partnership that also includes Pakistan, Australia, Bahrain, Denmark, Egypt, France, Germany and Greece, among others.
That temples were destroyed and mosques built is undisputed history. The past can’t be changed, but we can’t deny the wrongs of the past either before we consider reconciliation.